ALB and stage 5 chronic kidney disease: The AOPP content of 1 mg/mL of in vitro-generated AOPP-albumin was 7.0 μmol/L and was comparable to the AOPP content of isolated albumin from end stage renal disease patients which ranges from 2 to 10 μmol/L10.